Abiopharma

🔍 Almstead Neil Gregory (Executive)

Company: PTC THERAPEUTICS, INC. (PTCT)

Report Date: 2026-01-06

Detailed Transactions and Holdings:

• Sold 1,279 shares of Common Stock at $76.95 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,103.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 54 shares of Common Stock at $76.95 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,902.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,026 shares of Common Stock at $77.48 per share (Direct)
  Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 116,077.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 52 shares of Common Stock at $77.48 per share (Direct)
  Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,850.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,750 RSUs from a January 3, 2025 grant of 19,000 RSUs.
• F2: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 178 RSUs from a January 3, 2025 grant of 715 RSUs.
• F3: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs.
• F4: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 177 RSUs from a January 5, 2023 grant of 710 RSUs.